Research Institute for complex problems of cardiovascular diseases
Research Institute for complex problems of cardiovascular diseases
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Research Institute for complex problems of cardiovascular diseases: Innovative approaches in research and therapyDasusgehend of the global challenge posed by cardiovascular disease (CVD) has been established in the research Institute for complex problems of cardiovascular diseases. The Institute aims to investigate the multifactorial causes of these diseases, systematically, and to develop innovative therapeutic approaches tailored to individual patient characteristics.Focus of the researchThe fields of action of the Institute include several areas of focus:The genetic and molecular mechanisms. By means of high-throughput sequencing and bioinformatic analysis of genetic risk factors that contribute to diseases such as atherosclerosis, heart failure, or arrhythmic disorders. A special focus of the investigation is not considered epigenetic changes, and the role of non-coding RNA molecules.Predictive modeling and AI applications. The Institute develops machine learning algorithms to the individual's risk for heart attack or stroke, a more precise estimate. Data based on multi-modal data, including electronic health records, imaging data (e.g., Cardiac MRI) and biochemical markers.Personalized Therapy Concepts. On the Basis of the findings of personalized treatment strategies will be developed. These include targeted pharmacotherapy, minimally invasive procedures for heart valve repair, as well as innovative approaches of regenerative medicine (e.g., stem-cell therapy).Prevention and Public Health. The Institute is involved in epidemiological studies, to evaluate the effectiveness of prevention measures (e.g., lowering blood pressure, lowering cholesterol, lifestyle changes), and evidence-based recommendations for health policy to derive.Methodological ApproachThe research at the Institute follows an interdisciplinary approach that integrates the following methods:In‑vitro and in‑vivo model systems (e.g., transgenic mouse models);Clinical intervention trials (Phase II/III);Big Data analysis with the methods of Deep Learning;Multi-centric cohort studies with long-term observation.International networking and TransferThe Institute maintains close cooperation with leading institutions in Europe and North America. The results are regularly published in prestigious journals and in the clinical practice. In addition, the Institute offers a comprehensive training program for young scientists:indoor and clinicians:the inside.ViewThrough the systematic exploration of complex cardiovascular diseases, the Institute opens new perspectives for the prevention, diagnosis and therapy. The long-term goal is to improve the quality of life and life expectancy of patients around the world in a sustainable way.
My sudden blood pressure diagnosis came at a time when I was too stressed. I was getting frequent headaches but always associated with long hours in front of the screen. Dr. told me to control my blood pressure with medicines, lifestyle changes and diet, or I could get a stroke. My husband bought me Cardio Balance to help me lower down my bp naturally. He was the one who monitored my reading. And to our amazement, it reduced from around 145/115 to 124/82 and stayed there. Honestly, it’s a lifesaver for me. Research Institute for complex problems of cardiovascular diseases. My sudden blood pressure diagnosis came at a time when I was too stressed. I was getting frequent headaches but always associated with long hours in front of the screen. Dr. told me to control my blood pressure with medicines, lifestyle changes and diet, or I could get a stroke. My husband bought me Cardio Balance to help me lower down my bp naturally. He was the one who monitored my reading. And to our amazement, it reduced from around 145/115 to 124/82 and stayed there. Honestly, it’s a lifesaver for me.
Diet therapy in cardiovascular diseases, the list of literature
Nutrition in cardiovascular disease looks
Nursing process of cardiovascular diseases
rabota-dnr.ru/articles/13731-the-program-for-the-treatment-of-cardiovascular-diseases.html
new.a-g.site/posts/54582-what-type-of-cardiovascular-disease-are-known.html
Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo. Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo.
Cardiovascular disease: mortality and social impactCardiovascular disease (CVD) is the leading cause of death, and thus have a significant health political significance. According to data from the world health organization (WHO) die each year, approximately 17.9 million people to the consequences of cardiovascular disease, which corresponds to approximately 32% of all deaths worldwide.In Europe, a similar pattern: heart disease for more than 45% of the deaths. In Germany, more than 300000 fatalities is estimated that every year on cardiovascular disease. This is especially to the following conditions:Coronary heart disease (CHD) is the most common cause of death within the group of CVD.Stroke: A more significant cause of death and long-term disabilities.Heart failure is A result of various heart diseases, which is associated with a high mortality rate.Arrhythmias and other heart rhythm disorders: Can lead to sudden cardiac death.Demographic and risk factorsThe mortality due to cardiovascular disease varies by age, gender and socio-economic factors. Elderly people in particular are affected: About 75% of CVD deceased persons older than 70 years. Men have compared to women in the younger age groups have a higher mortality rate, while the differences in advanced age decrease.Among the most important modifiable risk factors:High Blood Pressure (Hypertension),elevated cholesterol levels (Dyslipidamie),Diabetes mellitus,SmokingOverweight and obesity,lack of physical activity,unhealthy diet.Trends and prevention measuresIn spite of the high Mortality in the last decades in many industrialized countries could be observed rates, a decrease in the CVD-associated mortality. This is mainly due to:Advances in the medical treatment (e.g., early revascularisation for myocardial infarction),more effective prevention strategies and awareness campaigns,Reduction of risk factors (e.g., drop in the Smoking rate)due to the. At the same time, the burden of CVD in Emerging and developing countries, which is a global priority in health care policy is on the rise.ConclusionCardiovascular diseases cause worldwide each year, and nearly 18 million deaths. The implementation of prevention programs, early diagnosis and adequate treatment are crucial to reduce this number in the future and to improve the quality of life and expectations of the population.
